| 1 |
33974505 | Association of polymorphism of CYP3A4, ABCB1, ABCC2, ABCG2, NFKB1, POR, and PXR with the concentration of cyclosporin A in allogeneic haematopoietic stem cell transplantation recipients. | 2021 Jul |
3 |
| 2 |
33991364 | Increased systemic exposure of once-daily tacrolimus in renal transplant recipients on marine omega-3 fatty acid supplementation. | 2021 Jul |
1 |
| 3 |
34306041 | CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation? | 2021 |
1 |
| 4 |
31248333 | Interaction Between Cyclosporine and Palbociclib in a Renal Transplant Patient: Case Report and Pharmacokinetic Perspective. | 2020 Dec |
1 |
| 5 |
32162881 | Severe Anaphylaxis During Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Aplastic Anemia: Case Report of Individualized Pharmaceutical Care and Literature Review. | 2020 Mar 1 |
1 |
| 6 |
32222391 | Worsening of Kidney Transplant Function During 2-Year Follow-up Is Associated With the Genetic Variants of CYP3A4, MDR1, and UGT1A9. | 2020 Oct |
1 |
| 7 |
32682934 | Incorporating nonlinear kinetics to improve predictive performance of population pharmacokinetic models for ciclosporin in adult renal transplant recipients: A comparison of modelling strategies. | 2020 Oct 1 |
2 |
| 8 |
32967779 | Applications of a grid-based CYP3A4 Template system to understand the interacting mechanisms of large-size ligands; part 4 of CYP3A4 Template study. | 2020 Dec |
1 |
| 9 |
30378493 | Metabolic Pathway of Cyclosporine A and Its Correlation with Nephrotoxicity. | 2019 |
1 |
| 10 |
30799432 | Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients. | 2019 Feb 25 |
3 |
| 11 |
30799725 | The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients. | 2019 Apr |
1 |
| 12 |
30912163 | Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers. | 2019 Jul |
3 |
| 13 |
31156436 | A Single Dose of Baicalin Has No Clinically Significant Effect on the Pharmacokinetics of Cyclosporine A in Healthy Chinese Volunteers. | 2019 |
1 |
| 14 |
31261526 | Correlation between gene polymorphism and blood concentration of calcineurin inhibitors in renal transplant recipients: An overview of systematic reviews. | 2019 Jun |
2 |
| 15 |
31385766 | Association Between CYP3A4 and CYP3A5 Genotypes and Cyclosporine's Blood Levels and Doses among Jordanian Kidney Transplanted Patients. | 2019 |
6 |
| 16 |
29678659 | Association of CYP3A4*1B genotype with Cyclosporin A pharmacokinetics in renal transplant recipients: A meta-analysis. | 2018 Jul 20 |
9 |
| 17 |
29712725 | Quantitative Analysis of Complex Drug-Drug Interactions between Cerivastatin and Metabolism/Transport Inhibitors Using Physiologically Based Pharmacokinetic Modeling. | 2018 Jul |
1 |
| 18 |
29801578 | The Pharmacogenetics of Immune-Modulating Therapy. | 2018 |
1 |
| 19 |
30044899 | Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers. | 2018 Nov |
1 |
| 20 |
28479356 | Quantitative Analysis of Complex Drug-Drug Interactions Between Repaglinide and Cyclosporin A/Gemfibrozil Using Physiologically Based Pharmacokinetic Models With In Vitro Transporter/Enzyme Inhibition Data. | 2017 Sep |
1 |
| 21 |
28616429 | Evaluation of the Interaction of Intravenous and Oral Voriconazole with Oral Cyclosporine in Iranian HSCT Patients. | 2017 Apr-Jun |
2 |
| 22 |
28722255 | Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. | 2017 Oct |
1 |
| 23 |
28952408 | Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients. | 2017 Nov |
2 |
| 24 |
29135906 | Effect of Age and Allele Variants of CYP3A5, CYP3A4, and POR Genes on the Pharmacokinetics of Cyclosporin A in Pediatric Renal Transplant Recipients From Serbia. | 2017 Dec |
5 |
| 25 |
26259716 | Mechanistic understanding of the nonlinear pharmacokinetics and intersubject variability of simeprevir: A PBPK-guided drug development approach. | 2016 Feb |
1 |
| 26 |
26353895 | Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir. | 2016 Feb |
2 |
| 27 |
26385839 | Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions. | 2016 Mar |
1 |
| 28 |
26713664 | Targeting myocardial reperfusion injuries with cyclosporine in the CIRCUS Trial - pharmacological reasons for failure. | 2016 Apr |
4 |
| 29 |
26912097 | Clinical determinants of calcineurin inhibitor disposition: a mechanistic review. | 2016 |
2 |
| 30 |
26950050 | CYP3A activity: towards dose adaptation to the individual. | 2016 May |
1 |
| 31 |
27310200 | Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients. | 2016 Oct |
1 |
| 32 |
27519420 | Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report. | 2016 Aug 12 |
1 |
| 33 |
25240575 | Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients. | 2015 Jan |
9 |
| 34 |
25512016 | Increased dosage of cyclosporine induces myopathy with increased seru creatine kinase in an elderly patient on chronic statin therapy. | 2015 Apr |
1 |
| 35 |
25644970 | Association of CYP3A variants with kidney transplant outcomes. | 2015 May |
1 |
| 36 |
25976223 | CYP3A4∗18B and CYP3A5∗3 polymorphisms contribute to pharmacokinetic variability of cyclosporine among healthy Chinese subjects. | 2015 Aug 30 |
3 |
| 37 |
26150050 | Evaluation of 6β-Hydroxycortisol and 6β-Hydroxycortisone as Biomarkers for Cytochrome P450 3A Activity: Insight into Their Predictive Value for Estimating Oral Immunosuppressant Metabolism. | 2015 Oct |
1 |
| 38 |
26271661 | Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients. | 2015 Dec |
2 |
| 39 |
26301745 | Transport and uptake of clausenamide enantiomers in CYP3A4-transfected Caco-2 cells: An insight into the efflux-metabolism alliance. | 2015 Nov 1 |
1 |
| 40 |
26817280 | A non-invasive CYP3A4 biomarker and body mass index predict cyclosporine dosage requirements in Chinese renal transplant recipients. | 2015 Dec |
3 |
| 41 |
24369269 | Successful telaprevir treatment in combination of cyclosporine against recurrence of hepatitis C in the Japanese liver transplant patients. | 2014 |
1 |
| 42 |
24522145 | Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation. | 2014 Feb 12 |
1 |
| 43 |
24527031 | Cyclosporine and herbal supplement interactions. | 2014 |
1 |
| 44 |
24658827 | The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. | 2014 Jun |
4 |
| 45 |
24691060 | Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients. | 2014 Jun |
5 |
| 46 |
24739665 | Pharmacokinetic drug interaction between cyclosporine and imatinib in bone marrow transplant children and model-based reappraisal of imatinib drug interaction profile. | 2014 Dec |
1 |
| 47 |
24739669 | CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients. | 2014 Dec |
1 |
| 48 |
24990333 | The proton pump inhibitor lansoprazole, but not rabeprazole, the increased blood concentrations of calcineurin inhibitors in Japanese patients with connective tissue diseases. | 2014 |
1 |
| 49 |
25125033 | [Lacidipine efficacy and safety for high blood pressure treatment in pediatric oncohematology]. | 2014 Oct |
1 |
| 50 |
25280976 | Pharmacokinetic drug-drug interaction of calcium channel blockers with cyclosporine in hematopoietic stem cell transplant children. | 2014 Dec |
2 |